https://www.selleckchem.com/pr....oducts/mivebresib-ab
Hypertriglyceridaemia has been associated with cardiovascular disease risk in humans for several decades. However, only recently, data from basic research, as well as from genetic and observational studies, have suggested triglyceride-rich lipoproteins (TRLs) as causal factors for atherosclerotic cardiovascular disease. Novel findings highlighting the relevance of TRL-derived lipolytic products (remnant lipoprotein particles "RLPs", rather than plasma triglycerides or TRL themselves, as the true mediators in atherosclerosis
Aimer
Commentaire
Partagez
